July 15, 2022 News by Lindsey Shapiro, PhD Helius Offers Online PoNS Training to MS Patients’ Therapists Helius Medical Technologies has launched an online training module for physical therapists who wish to use the company’s Portable Neuromodulation Stimulator (PoNS) device to treat gait deficits in people with multiple sclerosis (MS). The on-demand training modules for healthcare providers in the U.S. are now live, with…
June 9, 2022 News by Marta Figueiredo, PhD PoNS Device Improves Walking Skills Early On, New Data Show Using the portable neuromodulation stimulatorĀ (PoNS) device during a targeted exercise program significantly improves walking skills in people with multiple sclerosisĀ (MS), according to recent real-word data. Notably, significant improvements were observed from the second week onward, and more than half of the 42 patients patients experienced clinically meaningful gains…
April 29, 2022 News by Lindsey Shapiro, PhD PoNS Device for MS-associated Gait Problems Now Available in US The portable neuromodulation stimulator (PoNS) device, which improves walking abilities in people with multiple sclerosis (MS), is now available commercially in the U.S. for patients ages 22 and older who have a prescription from their healthcare provider. The device was approved last year by the U.S. Food…
August 20, 2021 News by Marisa Wexler, MS PoNS Stimulation Device for MS Gait Problems Due in US Next Year PoNS, a non-invasive devise to accompany physical therapy in multiple sclerosis (MS) patients with difficulty walking, will be available on the U.S. market early next year, its developer, Helius Medical Technologies, announced in a quarterly financial update. Short for Portable Neuromodulation Stimulator, the PoNS…
March 29, 2021 News by Marisa Wexler, MS PoNS Device to Help Adults in Rehab for Walking Problems Gets FDA Approval The U.S. Food and Drug Administration (FDA) has authorized the use of a medical device called Portable Neuromodulation StimulatorĀ or PoNS as a short-term treatment for walking difficulties in people with multiple sclerosis (MS). PoNS, developed by Helius Medical Technologies, is a non-invasive medical device…
January 12, 2021 News by Marisa Wexler, MS Helius Provides More Information to FDA About PoNS Device Helius Medical Technologies has submitted its response to the U.S. Food and Drug Administration (FDA)’s request for more information about the company’s application for de novoĀ classification and clearance of its portable neuromodulation stimulator (PoNS) device to help treat walking difficulties in people…
October 16, 2020 News by Joana Carvalho, PhD Helius to Survey MS Users of Emilyn App in US With Gait Problems for PoNS Device Helius Medical TechnologiesĀ partnered withĀ Breakthrough HealthĀ on a project focused on understanding how people with multiple sclerosis (MS) in the U.S. evaluate the therapies at their disposal in terms of how well they help their ability to walk. The collaboration will take advantage of an MS companion application, called…
February 13, 2017 News by Patricia Silva, PhD Tongue Stimulation Could Give MS Patients Better Rehabilitation Outcomes, Study Suggests Multiple sclerosis (MS) patients given gentleĀ electrical stimulation to their tongues during physical and cognitive rehabilitation training benefited more than those who did not have the stimulation,Ā a small pilot study demonstrated. Those who received the weak stimulation had significant improvements in balance and better scores than controls in cognition and other…
June 24, 2016 News by InĆŖs Martins, PhD Study Finds PoNS Neurostimulator Plus Physical Therapy of Benefit to Advanced MS Patients Helius Medical Technologies announced results of a pilot study, demonstrating the benefits ofĀ PoNS Therapy ā aĀ combination of the investigational Portable Neuromodulation Stimulator (PoNS) device with physical therapy ā in patients with advanced multiple sclerosis (MS). Specifically, the treatmentĀ was seen to improve both patients’ quality of life, andĀ physical and…
November 3, 2015 News by Patricia Silva, PhD Multiple Sclerosis Pilot Study Evaluating PoNS Yields Promising Results Helius Medical Technologies, Inc., a company dedicated to neurological wellness, recently announced that the multiple sclerosis (MS) pilot study assessing the companyās investigational Portable Neuromodulation Stimulator (PoNSā¢) device has met all of the studyās goals. PoNS is a non-invasive device that allows the delivery of neurostimulation through the…